Cancer
Malignant Uterine Corpus Neoplasm
CI-CAN-00008020Explore in graph →
Top-level411 active trials4 approved drugs28 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00008020Explore in graph →
Clinical trials
1,571 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (168)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05378152 | Assessing the Benefit of Pipelle Biopsy in Patients With Postmenopausal Bleeding and an Atrophic-appearing Cavity | completed | N/A | 82 | Royal College of Surgeons, IrelandOTHER | 1 | Apr 23, 2024 | clinicaltrials |
| NCT01526655 | Robot Assisted Laparoscopic Hysterectomy vs. Abdominal Hysterectomy in Endometrial Cancer | completed | N/A | 50 | University Hospital, LinkoepingOTHER | 1 | Apr 18, 2024 | clinicaltrials |
| NCT04298827 | Gyn Onc Prehab Study | completed | N/A | 83 | St. Louis UniversityOTHER | 1 | Apr 8, 2024 | clinicaltrials |
| NCT06049693 | Iron Prehabilitation in Endometrial Cancer(IROGYN) | completed | Phase 4 | 156 | National and Kapodistrian University of AthensOTHER | 1 | Mar 29, 2024 | clinicaltrials |
| NCT01886066 | Accuracy of Sentinel Lymph Node Biopsy in Nodal Staging of High Risk Endometrial Cancer(EndoSLN) | completed | N/A | 156 | University Health Network, TorontoOTHER | 1 | Mar 15, 2024 | clinicaltrials |
| NCT03339843 | Multiorgan Metabolic Imaging Response Assessment of Abemaciclib(MiMe-A) | completed | Phase 2 | 85 | Jules Bordet InstituteOTHER | 2 | Mar 15, 2024 | clinicaltrials |
| NCT03189446 | Vaginal Cuff Brachytherapy Followed by Chemotherapy in Endometrial Cancer | completed | Phase 2 | 39 | University of OklahomaOTHER | 1 | Mar 8, 2024 | clinicaltrials |
| NCT03665285 | A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors | completed | Phase 1 / Phase 2 | 109 | NextCure, Inc.INDUSTRY | 1 | Mar 8, 2024 | clinicaltrials |
| NCT00020267 | Vaccine Therapy in Treating Patients With Metastatic Cancer | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2024 | clinicaltrials |
| NCT01865929 | Minimally Invasive Benign Hysterectomy | completed | N/A | 124 | Region SkaneOTHER | 1 | Mar 4, 2024 | clinicaltrials |
| NCT03476798 | Bevacizumab and Rucaparib in Recurrent Carcinoma of the Cervix or Endometrium(Clovis-001) | completed | Phase 2 | 49 | University of OklahomaOTHER | 1 | Feb 15, 2024 | clinicaltrials |
| NCT03015129 | A Study of Durvalumab With or Without Tremelimumab in Endometrial Cancer | completed | Phase 2 | 80 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 6, 2024 | clinicaltrials |
| NCT05529303 | Prolonged Grief and Perception of Femininity in Gynecological Cancer Patients | completed | N/A | 80 | Kevser PamukOTHER | 1 | Feb 1, 2024 | clinicaltrials |
| NCT00342446 | A Follow-up Study of Women Evaluated and Treated for Infertility | completed | — | 12,193 | National Cancer Institute (NCI)NIH | 1 | Jan 11, 2024 | clinicaltrials |
| NCT04212377 | Dendritic Cells for Immunotherapy of Metastatic Endometrial Cancer Patients(DECENDO) | completed | Phase 2 | 8 | Radboud University Medical CenterOTHER | 1 | Jan 11, 2024 | clinicaltrials |
| NCT03454451 | CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers | completed | Phase 1 | 117 | Corvus Pharmaceuticals, Inc.INDUSTRY | 2 | Dec 21, 2023 | clinicaltrials |
| NCT03211481 | Design of an Intra-operative Blood Conservation Pathway at Open Myomectomy | completed | — | 24 | Unity Health TorontoOTHER | 1 | Dec 13, 2023 | clinicaltrials |
| NCT02413606 | ENdometrial Cancer SURvivors' Follow-up carE (ENSURE): Less is More?(ENSURE) | completed | N/A | 319 | Comprehensive Cancer Centre The NetherlandsOTHER | 1 | Dec 6, 2023 | clinicaltrials |
| NCT03367923 | Health and Recovery Program in Increasing Physical Activity Level in Stage IA-IIIA Endometrial Cancer Survivors | completed | Phase 2 | 47 | Stanford UniversityOTHER | 1 | Nov 28, 2023 | clinicaltrials |
| NCT06148129 | Immunohistochemistry Role in Better Prognosis of Endometrial Carcinoma Patients | completed | N/A | 96 | Zagazig UniversityOTHER_GOV | 1 | Nov 28, 2023 | clinicaltrials |
| NCT04474184 | Development of a New Early Detection Test to Reduce Racial Disparities in Endometrial Cancer (EC) Death Rates | completed | Phase 1 | 33 | Mayo ClinicOTHER | 1 | Nov 18, 2023 | clinicaltrials |
| NCT06115577 | Endometrial Tissues and Mononuclear Cells Receptivity in Pathogenesis of Endometrial Proliferative Processes | completed | — | 92 | Pirogov Russian National Research Medical UniversityOTHER | 0 | Nov 15, 2023 | clinicaltrials |
| NCT05986266 | Evaluating Efficacy of Intravenous Carbetocin Versus Intramyometrial Injection of Adrenaline in Reducing Blood Loss | completed | Phase 1 | 62 | EgymedicalpediaINDUSTRY | 1 | Oct 17, 2023 | clinicaltrials |
| NCT04534309 | Behavioral Weight Loss Program for Cancer Survivors in Maryland(ASPIRE) | completed | N/A | 340 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Oct 10, 2023 | clinicaltrials |
| NCT04021459 | Research of Circulating Tumor Cells Released During Endometrial Cancer Surgery.(E-CTC) | completed | N/A | 15 | University Hospital, MontpellierOTHER | 1 | Oct 3, 2023 | clinicaltrials |
| NCT02744898 | A Phase 2 Feasibility Study of Abraxane and Carboplatin in Epithelial Neoplasms of the Uterus | completed | Phase 2 | 23 | NYU Langone HealthOTHER | 1 | Sep 26, 2023 | clinicaltrials |
| NCT02465541 | Gentle Yoga and Dietary Counseling in Improving Physical Function and Quality of Life in Stage I-II Endometrial Cancer Survivors | completed | N/A | 16 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Sep 15, 2023 | clinicaltrials |
| NCT01397877 | GINECO-EN102b - BKM120 as Monotherapy in the Treatment of Initial or Recurrent Metastatic Endometrial Cancer(ENDOPIK) | completed | Phase 2 | 24 | ARCAGY/ GINECO GROUPOTHER | 1 | Sep 6, 2023 | clinicaltrials |
| NCT05364905 | Patients Characteristics, Treatment Pattern & Outcomes of Patients With Advanced, Recurrent or Metastatic Endometrial Carcinoma(ENDOVIE) | completed | — | 200 | ARCAGY/ GINECO GROUPOTHER | 1 | Sep 6, 2023 | clinicaltrials |
| NCT04590248 | A Study of Adavosertib as Treatment for Uterine Serous Carcinoma(ADAGIO) | completed | Phase 2 | 109 | AstraZenecaINDUSTRY | 5 | Aug 14, 2023 | clinicaltrials |
| NCT04705649 | Tailored Adjuvant Therapy in POLE-mutated and p53-wildtype Early Stage Endometrial Cancer(TAPER) | completed | N/A | 42 | British Columbia Cancer AgencyOTHER | 1 | Aug 14, 2023 | clinicaltrials |
| NCT00053794 | Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma | completed | Phase 2 | 17 | NCIC Clinical Trials GroupNETWORK | 1 | Aug 4, 2023 | clinicaltrials |
| NCT00770185 | Ridaforolimus in Treating Patients With Recurrent Metastatic and/or Locally Advanced Endometrial Cancer | completed | Phase 2 | 35 | NCIC Clinical Trials GroupNETWORK | 1 | Aug 4, 2023 | clinicaltrials |
| NCT02988817 | Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors | completed | Phase 1 / Phase 2 | 306 | GenmabINDUSTRY | 6 | Aug 1, 2023 | clinicaltrials |
| NCT04318340 | A Novel Tapered Applicator for Vaginal Vault Brachytherapy | completed | N/A | 21 | Yale UniversityOTHER | 1 | Jul 14, 2023 | clinicaltrials |
| NCT05086770 | Comparison of Pain After Uterine Artery Embolization Using Gelatin Microsphere or Tris-acryl Gelatin Microsphere | completed | N/A | 60 | Next Biomedical Co., Ltd.INDUSTRY | 1 | Jul 14, 2023 | clinicaltrials |
| NCT03339765 | Self-Advocacy Serious Game in Advanced Cancer | completed | N/A | 78 | University of PittsburghOTHER | 1 | Jul 5, 2023 | clinicaltrials |
| NCT04874246 | Comparison of Concentration of Vasopressin During Robot-assisted Laparoscopic Myomectomy(VALENTINE) | completed | N/A | 39 | Seoul National University HospitalOTHER | 1 | Jun 26, 2023 | clinicaltrials |
| NCT01111461 | Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression | completed | Phase 2 | 133 | Eisai Inc.INDUSTRY | 8 | Jun 22, 2023 | clinicaltrials |
| NCT01686256 | Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Women With Suspected Ovarian or Endometrial Cancer | completed | Phase 1 | 12 | EndocyteINDUSTRY | 1 | Jun 22, 2023 | clinicaltrials |
| NCT01689714 | Safety and Efficacy of Folatescan (Technetium TC 99M EC20) in Patients With Suspected Ovarian Carcinoma or Recurrent Endometrial Carcinoma | completed | Phase 2 | 16 | EndocyteINDUSTRY | 0 | Jun 22, 2023 | clinicaltrials |
| NCT04177693 | Pharmacokinetics and Hepatic Safety of EGCG | completed | Phase 1 | 39 | Yale UniversityOTHER | 1 | Jun 5, 2023 | clinicaltrials |
| NCT01367002 | Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer | completed | Phase 2 | 61 | Yale UniversityOTHER | 1 | May 17, 2023 | clinicaltrials |
| NCT02690766 | Translating Healthy Lifestyle Interventions for Cancer Survivors | completed | N/A | 17 | University of North Carolina, Chapel HillOTHER | 0 | May 16, 2023 | clinicaltrials |
| NCT03989661 | Is There a Place for Pre-operative Temporary Embolization of Uterine Fibroids(EMBOFIB) | completed | — | 119 | Fondation Hôpital Saint-JosephOTHER | 1 | Apr 27, 2023 | clinicaltrials |
| NCT03927651 | ICG to Assess Ovarian Perfusion | completed | Early Phase 1 | 54 | Northwestern UniversityOTHER | 1 | Apr 18, 2023 | clinicaltrials |
| NCT04281043 | Quality of Life After Robotic Surgery for Endometrial Cancer(QoL) | completed | — | 64 | Sahlgrenska University HospitalOTHER | 1 | Apr 12, 2023 | clinicaltrials |
| NCT03849469 | A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors(DUET-4) | completed | Phase 1 | 78 | Xencor, Inc.INDUSTRY | 1 | Mar 30, 2023 | clinicaltrials |
| NCT01818739 | Lymph Node Mapping in Patients With Endometrial Cancer | completed | N/A | 204 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Mar 22, 2023 | clinicaltrials |
| NCT03985449 | Implementation of Uterine Fibroid Option Grid Patient Decision Aids Across Five Organizational Settings(UPFRONT) | completed | N/A | 748 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Feb 28, 2023 | clinicaltrials |
Data updated 23 days agoSource updated Apr 23, 2024source: clinicaltrials